HEALI AI
Heali is a platform created to help users personalized nutrition using machine learning and their proprietary database. It was founded by Kyle Dardashti and William Brendel in 2018 and is headquartered in Santa Monica, California.
HEALI AI
Industry:
Artificial Intelligence Health Care Machine Learning Medical Nutrition Therapeutics
Founded:
2018-01-01
Address:
Santa Monica, California, United States
Country:
United States
Website Url:
http://www.heali.ai
Total Employee:
11+
Status:
Active
Contact:
949.395.5606
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Font API Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins Nginx Euro Google Apps For Business Gravatar Profiles
Similar Organizations
Ashley
Ashley is a personal AI assistant, a scheduling master, equipped with infinite patience.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Fitly
Fitly is the creator of SmartPlate, the world's only intelligent nutrition platform.
MiddleGate
Hello; my name is Grace. I am the smartest Machine Intelligence to ever power medical billing. Never chase underpaid claims again.
MiDr
MiDr is a Platform for AI diagnosis tool from medical records for latin america
Mr Young
AI-powered chatbot to help people cope with anxiety
MyFavorEats
MyFavorEats is a platform that helps users to create personalized recipes.
Current Employees Featured
Founder
Official Site Inspections
http://www.heali.ai
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Heali AI"
Healx announces agreement with Sanofi to seek new rare disease ...
Cambridge, UK, November 13, 2024 –Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, today announced it will use a Sanofi compound to identify new …See details»
Healx, an AI-enabled drug discovery platform for rare …
Aug 1, 2024 Healx, a U.K. startup using AI to discover new drugs for rare diseases, has raised $47 million in a Series C round of funding co-led by Europe’s Atomico and Silicon Valley-based R42.See details»
Healx to receive investment from Children’s Tumor …
Apr 11, 2024 Identified using Healx’s AI-informed approach, HLX-1502 has a novel mechanism of action, and is supported by data that suggest a favourable safety profile. ... The Children’s Tumor Foundation is the world’s leading …See details»
Healx to receive investment from Children’s Tumor …
Apr 11, 2024 Dr Annette Bakker, President, CTF said: “Patient-centric research holds a unique position in the R&D ecosystem and the Children’s Tumor Foundation is pleased to provide this approach to support Healx’s AI-driven …See details»
Healx Raises $56M to use AI to Find Treatments for …
Oct 16, 2019 Healx has secured $56M in new financing to build a clinical-stage portfolio for rare diseases, including treatments for Fragile X syndrome, and to launch a global Rare Treatment Accelerator program. Where the traditional …See details»
Healx Announces $47 million Series C Financing and FDA …
CAMBRIDGE, U.K., August 01, 2024--Healx, an AI-enabled, clinical-stage biotech company specializing in rare diseases, announced it has raised $47 million in a Series C round. The …See details»
Healx - Crunchbase Company Profile & Funding
Healx is a rare disease biotechnology company that uses generative AI for drug discovery. Healx utilizes advanced artificial intelligence (AI) and machine learning technologies to identify potential drug candidates and repurpose existing …See details»
Healx: AI-Powered, Patient-Inspired Treatments for Rare Diseases
Healx's AI platform, Healnet, overcomes these challenges by analyzing millions of drug and disease data points to find novel connections that could be turned into new treatment …See details»
Healx raises $56M Series B to use AI to find treatments …
Oct 16, 2019 Healx, a Cambridge, U.K.-based startup using AI to help discover new treatments for rare diseases, has raised $56 million in Series B funding.. Leading the round is London-base VC firm Atomico ...See details»
How third-generation drug discovery is transforming rare disease ...
With its Healnet platform, Healx pairs cutting-edge AI with industry-leading drug discovery and rare disease expertise to identify new uses for known compounds. The company now has over …See details»
Unleashing AI-Powered Treatments for Rare Diseases
May 1, 2024 think-In recap: Key Insights from a Trailblazing Co-founder and CEO . In this inspiring first Think-In webinar, we were taken on a fascinating journey by Dr Tim Guilliams, …See details»
About - Healx
Tim is a tech entrepreneur from the Cambridge Cluster, passionate about using big data and AI to accelerate treatments for rare diseases. He is the Co-Founder and Chief Executive of Healx, …See details»
Healx: How AI is rewriting the economics of rare disease drug
The Cambridge, UK-based startup is turning to the data-crunching power of artificial intelligence (AI) to rewrite the economics of drug discovery for the world’s rarest diseases. “It’s a huge …See details»
Clinical Trials Expand For AI-Designed Drug To Treat Fragile X
Oct 20, 2021 Founded in 2014, by Guilliams and David Brown, co-inventor of Viagra, Healx has raised a total of $66 million in a Series A and B round. It is one of a crop of British startups in …See details»
Healx - AI technology that finds treatments for rare ... - Balderton
The company uses artificial intelligence, deep pharmacology expertise, and one of the largest collection of insights from rare disease patient groups to find new approaches to treating these …See details»
Our technology and approach - Healx
Nov 1, 2019 The next generation of drug discovery is AI-powered, parallel and hypothesis-free. Bringing together the key three drug discovery paradigms. Our approach ... Healx Ltd. Charter …See details»
Singapore's IMAGINE AI: Largest Global Gathering to Shape the …
16 hours ago Key News Points. 2. The IMAGINE AI opening day event saw the introduction of a nurse companion robot, the NUHS MiSSi Robot.It is a cloud-based robot, connected via a …See details»
Jonathan Milner, Ph.D., Appointed as Non-Executive Chairman of …
3 days ago Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, today announced the appointment of Jonathan Milner, Ph.D., as the new non-executive …See details»
How gen AI enables the boundaryless organization | Fortune
22 hours ago How gen AI enables the boundaryless organization. BY Jack Azagury. This commentary is from Accenture, a sponsor of Fortune Analytics, Fortune Brainstorm AI and …See details»
How third-generation drug discovery is transforming rare disease ...
Healx www.healx.io How third-generation drug discovery is transforming rare disease treatment development With its Healnet platform, Healx pairs cutting-edge AI with industry-leading drug …See details»